New Hampshire Trust Sells 238 Shares of Danaher Corporation $DHR

New Hampshire Trust lowered its holdings in Danaher Corporation (NYSE:DHR) by 1.9% in the 2nd quarter, HoldingsChannel reports. The firm owned 12,281 shares of the conglomerate’s stock after selling 238 shares during the quarter. New Hampshire Trust’s holdings in Danaher were worth $2,426,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Oppenheimer Asset Management Inc. increased its holdings in shares of Danaher by 6.6% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 158,784 shares of the conglomerate’s stock valued at $31,366,000 after acquiring an additional 9,891 shares during the period. Ballast Advisors LLC increased its holdings in shares of Danaher by 6.3% in the 2nd quarter. Ballast Advisors LLC now owns 4,946 shares of the conglomerate’s stock valued at $977,000 after acquiring an additional 294 shares during the period. Brighton Jones LLC increased its holdings in shares of Danaher by 47.3% in the 2nd quarter. Brighton Jones LLC now owns 10,390 shares of the conglomerate’s stock valued at $2,052,000 after acquiring an additional 3,335 shares during the period. Stegent Equity Advisors Inc. increased its holdings in shares of Danaher by 60.5% in the 2nd quarter. Stegent Equity Advisors Inc. now owns 1,764 shares of the conglomerate’s stock valued at $348,000 after acquiring an additional 665 shares during the period. Finally, Linden Thomas Advisory Services LLC purchased a new position in shares of Danaher in the 2nd quarter valued at $252,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on DHR shares. Evercore ISI lifted their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. TD Cowen increased their target price on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Robert W. Baird set a $247.00 price objective on Danaher in a report on Wednesday. Finally, Barclays raised their price objective on Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Stock Performance

Shares of DHR opened at $223.03 on Friday. The stock has a 50-day moving average of $202.73 and a two-hundred day moving average of $198.53. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.22 and a current ratio of 1.52. The stock has a market cap of $157.54 billion, a P/E ratio of 45.99, a P/E/G ratio of 3.41 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the firm posted $1.71 EPS. The firm’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.